How to Test Human-Specific Combination Immunotherapies In Vivo

Learn how to evaluate combinations of human-specific checkpoint inhibitors in vivo, with double knock-in humanized drug target mouse models.

News: Editing Stem Cells In Vivo: A Major Stride in Gene Therapy for Blood Disorders - CRISPR Medicine

Tumor-specific cytolytic CD4 T cells mediate immunity against human cancer

Development of humanized mouse with patient‐derived xenografts for cancer immunotherapy studies: A comprehensive review - Jin - 2021 - Cancer Science - Wiley Online Library

State of the CAR-T: Risk of Infections with Chimeric Antigen Receptor T-Cell Therapy and Determinants of SARS-CoV-2 Vaccine Responses - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation

Catecholamines Induce Trained Immunity in Monocytes In Vitro and In Vivo

Combination therapy with immune checkpoint inhibitors (ICIs); a new frontier, Cancer Cell International

Pre-clinical data supporting immunotherapy for HIV using CMV-HIV-specific CAR T cells with CMV vaccine: Molecular Therapy - Methods & Clinical Development

The next wave of cellular immunotherapies in pancreatic cancer - ScienceDirect

Frontiers Clinical cancer immunotherapy: Current progress and prospects

Dendritic cell-based immunotherapy